US Edition[Opinion] Aemps Evaluates a New Advanced Therapy in Neoplasms After Ema Ok
Summary by redaccionmedica.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The Spanish Agency for Medicinal Products and Health Products (Aemps) has initiated the preparation of the Therapeutic Positioning Reports (IPT) for medicinal products that obtained a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) during its meeting in June this year. One of them corresponds to a new advanced therapy for patients with haematological neoplasms. Another four d…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
